← Back to Search

Behavioural Intervention

Attention Training for Long COVID (LongCovAtten Trial)

N/A

Recruiting

Led By Elliot Roth, MD

Research Sponsored by Shirley Ryan AbilityLab

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Objective attentional deficits as measured by the Conners CPT-312, and/or the Digit Span subtest (WAIS- III13)

Aged 18-65 years

Must not have

Severe depression

Being hospitalized due to COVID-19 diagnosis for more than 3 days

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 year

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if a training program can help with brain fog symptoms in Long-Covid patients and if the program can be done online. """ Desired output format: "This trial

Who is the study for?

This trial is for adults aged 18-65 who have had COVID-19 and are experiencing 'brain fog' that affects daily life. Participants must have attentional deficits, be able to use a keyboard, consent independently, and communicate in English. Those with severe depression, recent chemotherapy or radiation treatment, active substance abuse, or certain pre-existing neurological conditions cannot join.

What is being tested?

The study tests if an Attention Processing Training program can help improve the brain fog symptoms associated with Long-Covid. It also examines whether this training can be effectively completed online.

What are the potential side effects?

Since the interventions involve non-medical treatments like music therapy and attention training exercises, side effects may not apply as they would for drug trials. However, participants might experience fatigue or frustration.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have attention issues confirmed by specific tests.

Select...

I am between 18 and 65 years old.

Select...

I have had a confirmed case of COVID-19.

Select...

I can make my own medical decisions.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been diagnosed with severe depression.

Select...

I have been in the hospital for over 3 days due to COVID-19.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of participants who successfully completed at least 80% of the study tasks sessions

Secondary study objectives

Change of scores in objective attention tests (i.e, CPT 3), pre- and post -intervention

Other study objectives

Change of scores in objective attention tests (i.e, Digit Span), pre- and post -intervention

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Music ProgramExperimental Treatment1 Intervention

This group will receive an enhanced music experience. They will listen to pre determined music for 30 minutes per day, 5 days a week, for 4 weeks (10 hours total over 4 weeks). This will be delivered in a hybrid model that will combine, in person, remote, and independent sessions, similar to the Attention Training group. Once they complete the music program, they will have the option to complete the Attention Training.

Group II: Attention TrainingExperimental Treatment1 Intervention

The computer based APT-3 intervention will be delivered in a hybrid model that will combine in-person therapy sessions at Shirley Ryan AbilityLab and practice sessions which will be completed remotely. The dosing of each intervention training will be 30 minutes per day, 5 days a week, for 4 weeks (10 hours total over 4 weeks). The difficulty of the tasks in both interventions will increase progressively as the participants improve in their skills. APT-3 treatment will be administered by a trained and certified speech-language pathologist.

Group III: Delayed Attention TrainingActive Control1 Intervention

This group will not be provided any program for the initial 4 weeks. After they complete the week 5 assessments, they will have the option to complete the Attention Training.

0 / 6Eligibility criteria met